Logo image of ICCM

ICECURE MEDICAL LTD (ICCM) Stock Fundamental Analysis

NASDAQ:ICCM - Nasdaq - IL0011224156 - Common Stock - Currency: USD

1.015  +0.01 (+1%)

After market: 1.02 +0.01 (+0.49%)

Fundamental Rating

3

Taking everything into account, ICCM scores 3 out of 10 in our fundamental rating. ICCM was compared to 188 industry peers in the Health Care Equipment & Supplies industry. ICCM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ICCM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ICCM has reported negative net income.
In the past year ICCM has reported a negative cash flow from operations.
In the past 5 years ICCM always reported negative net income.
ICCM had a negative operating cash flow in each of the past 5 years.
ICCM Yearly Net Income VS EBIT VS OCF VS FCFICCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

ICCM has a Return On Assets of -137.76%. This is amonst the worse of the industry: ICCM underperforms 87.77% of its industry peers.
Looking at the Return On Equity, with a value of -254.95%, ICCM is doing worse than 77.13% of the companies in the same industry.
Industry RankSector Rank
ROA -137.76%
ROE -254.95%
ROIC N/A
ROA(3y)-89.11%
ROA(5y)-66.89%
ROE(3y)-136.41%
ROE(5y)-102.39%
ROIC(3y)N/A
ROIC(5y)N/A
ICCM Yearly ROA, ROE, ROICICCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800 1K

1.3 Margins

With a Gross Margin value of 42.77%, ICCM is not doing good in the industry: 64.36% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ICCM has grown nicely.
The Profit Margin and Operating Margin are not available for ICCM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.03%
GM growth 5Y4.86%
ICCM Yearly Profit, Operating, Gross MarginsICCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

5

2. Health

2.1 Basic Checks

ICCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ICCM has more shares outstanding
Compared to 5 years ago, ICCM has more shares outstanding
There is no outstanding debt for ICCM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ICCM Yearly Shares OutstandingICCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICCM Yearly Total Debt VS Total AssetsICCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

ICCM has an Altman-Z score of -10.95. This is a bad value and indicates that ICCM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ICCM (-10.95) is worse than 81.38% of its industry peers.
There is no outstanding debt for ICCM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.95
ROIC/WACCN/A
WACC9.83%
ICCM Yearly LT Debt VS Equity VS FCFICCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.89 indicates that ICCM should not have too much problems paying its short term obligations.
The Current ratio of ICCM (1.89) is worse than 67.55% of its industry peers.
ICCM has a Quick Ratio of 1.48. This is a normal value and indicates that ICCM is financially healthy and should not expect problems in meeting its short term obligations.
ICCM has a Quick ratio of 1.48. This is comparable to the rest of the industry: ICCM outperforms 42.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.48
ICCM Yearly Current Assets VS Current LiabilitesICCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

ICCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.26%, which is quite good.
ICCM shows a small growth in Revenue. In the last year, the Revenue has grown by 0.34%.
The Revenue has been growing by 15.37% on average over the past years. This is quite good.
EPS 1Y (TTM)10.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y-7.36%
Revenue growth 5Y15.37%
Sales Q2Q%-2.42%

3.2 Future

Based on estimates for the next years, ICCM will show a very strong growth in Earnings Per Share. The EPS will grow by 25.30% on average per year.
ICCM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 90.27% yearly.
EPS Next Y18.4%
EPS Next 2Y22.07%
EPS Next 3Y40.07%
EPS Next 5Y25.3%
Revenue Next Year69.88%
Revenue Next 2Y120.05%
Revenue Next 3Y139.27%
Revenue Next 5Y90.27%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICCM Yearly Revenue VS EstimatesICCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20M 40M 60M 80M 100M
ICCM Yearly EPS VS EstimatesICCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ICCM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICCM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ICCM Price Earnings VS Forward Price EarningsICCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICCM Per share dataICCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

ICCM's earnings are expected to grow with 40.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.07%
EPS Next 3Y40.07%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ICCM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ICECURE MEDICAL LTD

NASDAQ:ICCM (6/6/2025, 8:00:02 PM)

After market: 1.02 +0.01 (+0.49%)

1.015

+0.01 (+1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-28 2025-05-28/bmo
Earnings (Next)N/A N/A
Inst Owners0.27%
Inst Owner Change-20.29%
Ins Owners48.54%
Ins Owner ChangeN/A
Market Cap57.42M
Analysts82.22
Price Target3.07 (202.46%)
Short Float %0.81%
Short Ratio0.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.95%
Min EPS beat(2)-4.58%
Max EPS beat(2)26.47%
EPS beat(4)2
Avg EPS beat(4)8.32%
Min EPS beat(4)-4.58%
Max EPS beat(4)26.47%
EPS beat(8)6
Avg EPS beat(8)7.37%
EPS beat(12)9
Avg EPS beat(12)6.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-12.44%
Min Revenue beat(2)-19.65%
Max Revenue beat(2)-5.23%
Revenue beat(4)1
Avg Revenue beat(4)-6.54%
Min Revenue beat(4)-19.65%
Max Revenue beat(4)7.1%
Revenue beat(8)2
Avg Revenue beat(8)-13.6%
Revenue beat(12)2
Avg Revenue beat(12)-15.41%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.13%
PT rev (3m)-4.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.67%
EPS NY rev (1m)10%
EPS NY rev (3m)7.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-21.26%
Revenue NY rev (1m)-5.72%
Revenue NY rev (3m)5.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.54
P/FCF N/A
P/OCF N/A
P/B 9.57
P/tB 9.57
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.06
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -137.76%
ROE -254.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.77%
FCFM N/A
ROA(3y)-89.11%
ROA(5y)-66.89%
ROE(3y)-136.41%
ROE(5y)-102.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.03%
GM growth 5Y4.86%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.58%
Cap/Sales 1.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.89
Quick Ratio 1.48
Altman-Z -10.95
F-Score4
WACC9.83%
ROIC/WACCN/A
Cap/Depr(3y)175.33%
Cap/Depr(5y)260.07%
Cap/Sales(3y)15.28%
Cap/Sales(5y)12.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y18.4%
EPS Next 2Y22.07%
EPS Next 3Y40.07%
EPS Next 5Y25.3%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y-7.36%
Revenue growth 5Y15.37%
Sales Q2Q%-2.42%
Revenue Next Year69.88%
Revenue Next 2Y120.05%
Revenue Next 3Y139.27%
Revenue Next 5Y90.27%
EBIT growth 1Y-2.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.94%
OCF growth 3YN/A
OCF growth 5YN/A